The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
53 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $58,653,642 in first-year total cost, median $692,345.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BDCN-N (50)]10
- Special Emphasis Panel[ZRG1 BDCN-W (50)]6
- Special Emphasis Panel[ZRG1 MDCN-T (53)]5
- Special Emphasis Panel[ZRG1 HDM-Y (50)]4
- Special Emphasis Panel[ZRG1 MDCN-P (52)]4
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL3
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO3
- BOSTON UNIVERSITY MEDICAL CAMPUS2
- COLUMBIA UNIVERSITY HEALTH SCIENCES2
- GEORGIA STATE UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Glycoproteomics and the Glycosylation Code of the Brain in Asymptomatic and Symptomatic Alzheimer’s Disease1RF1AG062181-01 | CUMMINGS, RICHARD DSEYFRIED, NICHOLAS THOMAS | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $4,145,414 | ZRG1 |
| 2018 | Targeting a lipid-mediated pro-longevity pathway as Alzheimer's therapy1RF1AG062257-01 | WANG, JINZHENG, HUI | BAYLOR COLLEGE OF MEDICINE, TX | $3,942,988 | ZRG1 |
| 2018 | Dissection of endosomal trafficking mechanisms in Alzheimer's Disease1RF1AG062377-01 | TSAI, LI-HUEI | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $3,613,268 | ZRG1 |
| 2018 | Optogenetic dissection of cellular and circuit mechanisms of network dysfunction and amyloid deposition in mouse models of Alzheimer's disease in vivo1RF1AG062234-01 | PALOP, JORGE J | J. DAVID GLADSTONE INSTITUTES, CA | $3,540,000 | ZRG1 |
| 2018 | New mechanistic insights into how the gut metabolite urolithin A extends lifespan and prevents AD1RF1AG062280-01 | ANDERSEN, JULIE KAY | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | $3,414,407 | ZRG1 |
| 2018 | Age-Associated Modulation of Gene Expression in the CNS1RF1AG062220-01 | URBANSKI, HENRYK F | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $3,394,232 | ZRG1 |
| 2018 | SUGAR-seq: A New Technology for Single-Cell Glycan and Gene Expression Profiling in AD1RF1AG062324-01 | HSIEH-WILSON, LINDA C | CALIFORNIA INSTITUTE OF TECHNOLOGY, CA | $3,278,468 | ZRG1 |
| 2018 | Antibodies Against Conformationally Defined Amyloid Oligomers in Alzheimer’s Disease1RF1AG062296-01 | NOWICK, JAMES S | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $3,018,693 | ZRG1 |
| 2018 | Role of O-GlcNAcylation in Regulating Neurodegeneration in Aging and Alzheimer’s Disease1RF1AG062357-01 | VILLEDA, SAUL A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,011,875 | ZRG1 |
| 2018 | Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease1R01AG062335-01 | KELLIS, MANOLISTSAI, LI-HUEI | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $1,308,813 | ZRG1 |
| 2018 | PET Imaging of SV2A and Other Biomarkers in Alzheimer's Disease1R01AG062276-01 | VAN DYCK, CHRISTOPHER H | YALE UNIVERSITY, CT | $1,108,088 | ZRG1 |
| 2018 | Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease1R01AG062355-01 | EHRLICH, MICHELLE ESALTON, STEPHEN RZHANG, BIN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $867,487 | ZRG1 |
| 2018 | The Contribution of Age-Related Tauopathies to Alzheimer's Disease1R01AG062348-01 | CRARY, JOHN FONDADICKSON, DENNIS WILLIAMMCKEE, ANN C. | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $850,423 | ZRG1 |
| 2018 | Alzheimer's Disease and Related Dementia Care within the Medicare Program1R01AG062282-01 | HSU, JOHN | MASSACHUSETTS GENERAL HOSPITAL, MA | $849,724 | ZRG1 |
| 2018 | Optogenetic modulation and pathophysiological analysis of Alzheimer's disease.1R56AG062208-01 | NI, XINGJIEZHANG, CAN MARTIN | MASSACHUSETTS GENERAL HOSPITAL, MA | $823,571 | ZRG1 |
| 2018 | Construct large-scale phenomes of disease and drugs and develop data-driven systems approaches to understand genetic links between Alzheimer's disease and Neuropsychiatric symptoms1R56AG062272-01 | XU, RONG | CASE WESTERN RESERVE UNIVERSITY, OH | $789,910 | ZRG1 |
| 2018 | Computational Prediction and Functional Validation of Novel Epigenetic Risk Loci in Alzheimer's Disease1R56AG062256-01 | JIN, PENGQIN, ZHAOHUIWINGO, THOMAS SPURGEON | EMORY UNIVERSITY, GA | $788,285 | ZRG1 |
| 2018 | Shared genetic, epigenetic, and transcriptomic profiles between AD and PTSD: molecular insights into the heterogeneity of neuropsychiatric symptoms in Alzheimers Disease1R56AG062302-01 | CHIBA-FALEK, ORNITLUO, SHENGLUTZ, MICHAEL WILLIAMWILLIAMSON, DOUGLAS E | DUKE UNIVERSITY, NC | $788,011 | ZRG1 |
| 2018 | Innovative Glycomic/Glycoproteomic Investigation on Alzheimer’s Disease1R56AG062258-01 | LI, LIANYIN, JUN | GEORGIA STATE UNIVERSITY, GA | $782,675 | ZRG1 |
| 2018 | Indigenous Cultural Understandings of Alzheimer's Disease and Related Dementias - Research and Engagement (I-CARE)1R56AG062307-01 | JACKLIN, KRISTEN | UNIVERSITY OF MINNESOTA, MN | $782,089 | ZRG1 |
| 2018 | Defining the role of keratan sulfate recognition in Alzheimer's Disease progression1R56AG062342-01 | MOREMEN, KELLEY W.SCHNAAR, RONALD LWOODS, ROBERT J | UNIVERSITY OF GEORGIA, GA | $776,544 | ZRG1 |
| 2018 | Endosome Dysfunction in Alzheimer's Disease1R01AG062376-01 | NIXON, RALPH A. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $775,998 | ZRG1 |
| 2018 | The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program1R01AG062306-01 | ARNOLD, STEVEN ECARLYLE, BECKY CATHERINENAIRN, ANGUS C. | MASSACHUSETTS GENERAL HOSPITAL, MA | $775,203 | ZRG1 |
| 2018 | Palliative care needs and outcomes for dementia patients1R01AG062239-01 | PERIYAKOIL, VYJEYANTHI S | STANFORD UNIVERSITY, CA | $773,572 | ZRG1 |
| 2018 | SV2A PET imaging in Alzheimer's Disease1R01AG062285-01 | BENDLIN, BARBARA BRIGITTACHRISTIAN, BRADLEY TJOHNSON, STERLING C | UNIVERSITY OF WISCONSIN-MADISON, WI | $758,565 | ZRG1 |
| 2018 | Cellular senescence, inflammation and neurotransmission in Alzheimer's disease1R01AG061937-01 | HASCUP, ERIN R | SOUTHERN ILLINOIS UNIVERSITY SCH OF MED, IL | $708,790 | ZRG1 |
| 2018 | Molecular Mechanisms Underlying Behavioral and Psychological Symptoms in Alzheimers Disease1R01AG062249-01 | DONG, HONGXINWILSON, ROBERT S | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $692,345 | ZRG1 |
| 2018 | Meaningful Engagement and Quality of Life among Assisted Living Residents with Dementia1R01AG062310-01 | KEMP, CANDACE LYNN | GEORGIA STATE UNIVERSITY, GA | $683,835 | ZRG1 |
| 2018 | Role of Lipid-derived Oligomer Strains in AD Phenotypes1R56AG062292-01 | RANGACHARI, VIJAY | UNIVERSITY OF SOUTHERN MISSISSIPPI, MS | $671,162 | ZRG1 |
| 2018 | Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomics1R01AG062359-01 | KAMPMANN, MARTIN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $663,216 | ZRG1 |
| 2018 | Comprehensive Characterization of Glycosylation Alterations in Alzheimer’s Disease1R01AG062240-01 | JIN, LEE-WAYLEBRILLA, CARLITO BZIVKOVIC, ANGELA M | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $658,515 | ZRG1 |
| 2018 | Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.1R01AG062148-01 | YOUNG, JESSICA ELAINE | UNIVERSITY OF WASHINGTON, WA | $645,205 | ZRG1 |
| 2018 | Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches1R01AG062277-01 | GOLDMAN, DANA PLAKDAWALLA, DARIUS N. | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $626,769 | ZRG1 |
| 2018 | Access and use of long-term services and supports for older adults living alone with Alzheimer's disease and related dementias from four racial/ethnic groups1R56AG062165-01 | PORTACOLONE, ELENA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $617,406 | ZRG1 |
| 2018 | Effect of Hospital and Community Care Coordination on Health Care Access, Quality and Equity among Individuals with Risk Factors or Diagnosis of ADRD1R56AG062315-01 | CHEN, JIE | UNIV OF MARYLAND, COLLEGE PARK, MD | $617,127 | ZRG1 |
| 2018 | Regulation of retromer proteins through an Alzheimer's disease-specific transcription factor complex1R56AG062354-01 | HENGST, ULRICH | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $602,418 | ZRG1 |
| 2018 | Geroscience approaches to mitigate tauopathy in aged mouse brain1R01AG062217-01 | GORDON, MARCIA N | MICHIGAN STATE UNIVERSITY, MI | $599,789 | ZRG1 |
| 2018 | LOAD risk genes in postsynaptic endosomal trafficking1R56AG063433-01 | PENZES, PETER | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $544,013 | ZRG1 |
| 2018 | Golgi-mediated Glycosylation Defects in Alzheimer’s Disease1R56AG062225-01 | WANG, YANZHUANG | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $526,630 | ZRG1 |
| 2018 | Cognitive heterogeneity in those with high Alzheimer's Disease Risk1R56AG062109-01 | AU, RHODA | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $517,295 | ZRG1 |
| 2018 | Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's disease1R01AG062268-01 | HUEY, EDWARD D | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $496,686 | ZRG1 |
| 2018 | A quantitative framework for understanding endosomal trafficking networks in Alzheimer's disease1R01NS110395-01 | HARPER, JEFFREY W | HARVARD MEDICAL SCHOOL, MA | $482,307 | ZRG1 |
| 2018 | Glycosylation of the perineuronal net in Alzheimer's Disease1R56AG062232-01 | ESKO, JEFFREY DLEE, KUO-FEN | SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA | $459,954 | ZRG1 |
| 2018 | Delay of Alzheimer's phenotypes by interventions that increase lifespan1R01AG062303-01 | MOBBS, CHARLES V | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $423,750 | ZRG1 |
| 2018 | Axonal endo-lysosome transport mechanisms that regulate APP processing1R01AG062210-01 | FERGUSON, SHAWN | YALE UNIVERSITY, CT | $418,750 | ZRG1 |
| 2018 | Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage1R01AG063544-01 | CHANG, TA YUAN | DARTMOUTH COLLEGE, NH | $410,000 | ZRG1 |
| 2018 | Sleep consolidation as a neuroprotective therapy for Alzheimers disease1R56AG062293-01 | NAIDOO, NIRMALA NIRINJINI | UNIVERSITY OF PENNSYLVANIA, PA | $402,500 | ZRG1 |
| 2018 | Acceleration of AD Phenotypes in Asymptomatic Mouse Models1R01AG062251-01 | LAZAROV, ORLY | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $399,750 | ZRG1 |
| 2018 | Cerebrovascular Endothelial Function in Aging and Alzheimer's Disease1R56AG062169-01 | BEHRINGER, ERIK J. | LOMA LINDA UNIVERSITY, CA | $391,230 | ZRG1 |
| 2018 | Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis1R56AG062305-01 | FLOWERS, SARAH ANN | GEORGETOWN UNIVERSITY, DC | $388,750 | ZRG1 |
| 2018 | Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases1R01AG062254-01 | AYYADEVARA, SRINIVASSHMOOKLER REIS, ROBERT JOSEPH | UNIV OF ARKANSAS FOR MED SCIS, AR | $370,165 | ZRG1 |
| 2018 | Comparative analysis of geroprotective interventions in established and novel mouse models of Alzheimer's disease1R01AG062328-01 | LAMMING, DUDLEY WILLIAMMERRINS, MATTHEW J. | UNIVERSITY OF WISCONSIN-MADISON, WI | $364,982 | ZRG1 |
| 2018 | Network analysis for identifying disease mechanisms and therapeutic targets for dementia1R01AG062176-01 | POTASHKIN, JUDITH ANN | ROSALIND FRANKLIN UNIV OF MEDICINE & SCI, IL | $312,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.